Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells

Resveratrol, a naturally occurring stilbene, induced apoptosis in human breast cancer MCF-7 cells. The mechanism of this effect was dependent on mitogen-activated protein kinase (MAPK, ERK1/2) activation and was associated with serine phosphorylation and acetylation of p53. Treatment of MCF-7 cells with resveratrol in the presence of 17β-oestradiol (E2) further enhanced MAPK activation, but E2 blocked resveratrol-induced apoptosis, as measured by nucleosome ELISA and DNA fragmentation assays. E2 inhibited resveratrol-stimulated phosphorylation of serines 15, 20 and 392 of p53 and acetylation of p53 in a concentration- and time-dependent manner. These effects of E2 on resveratrol action were blocked by ICI 182,780 (ICI), an inhibitor of the nuclear oestrogen receptor-α (ER). ICI 182,780 did not block the actions of resveratrol, alone. Electrophoretic mobility studies of p53 binding to DNA and of p21 expression indicated that E2 inhibited resveratrol-induced, p53-directed transcriptional activity. These results suggest that E2 inhibits p53-dependent apoptosis in MCF-7 cells by interfering with post-translational modifications of p53 which are essential for p53-dependent DNA binding and consequent stimulation of apoptotic pathways. These studies provide insight into the complex pathways by which apoptosis is induced by resveratrol in E2-depleted and -repleted environments.

[1]  H. Samuels,et al.  Regulation of the mdm2 Oncogene by Thyroid Hormone Receptor , 1999, Molecular and Cellular Biology.

[2]  E. Diamandis,et al.  The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[3]  Z. Darżynkiewicz,et al.  Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. , 1999, International journal of oncology.

[4]  S. Berger,et al.  p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage , 1999, Molecular and Cellular Biology.

[5]  R. McPherson,et al.  The role of mitogen-activated protein (MAP) kinase in breast cancer , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  Yan Tang,et al.  Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  M V Chernov,et al.  A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. , 1999, Science.

[8]  Sudhir Agrawal,et al.  Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Klinge,et al.  Resveratrol Acts as a Mixed Agonist / Antagonist for Estrogen Receptors a and b * , 2000 .

[10]  B. Wasylyk,et al.  Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. , 2001, Genes & development.

[11]  Daniel Metzger,et al.  Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.

[12]  S. Mulero-Navarro,et al.  The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. , 2002, Biochemical pharmacology.

[13]  C. Wade,et al.  Estrogen activation of cyclic adenosine 5'-monophosphate response element-mediated transcription requires the extracellularly regulated kinase/mitogen-activated protein kinase pathway. , 2003, Endocrinology.

[14]  K. Sakaguchi,et al.  DNA damage activates p53 through a phosphorylation-acetylation cascade. , 1998, Genes & development.

[15]  R. Toillon,et al.  Normal breast epithelial cells induce p53-dependent apoptosis and p53-independent cell cycle arrest of breast cancer cells , 2002, Breast Cancer Research and Treatment.

[16]  S. Pervaiz,et al.  Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. , 1998, Blood.

[17]  J. Slingerland,et al.  Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Margaret Ashcroft,et al.  Regulation of p53 stability , 1999, Oncogene.

[19]  S. Berger,et al.  Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. , 2001, Molecular cell.

[20]  K. Sakaguchi,et al.  Human p53 Is Phosphorylated on Serines 6 and 9 in Response to DNA Damage-inducing Agents* , 2000, The Journal of Biological Chemistry.

[21]  G. Serrero,et al.  Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells , 1999, Journal of cellular physiology.

[22]  F. B. Davis,et al.  Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase. , 2001, Biochemistry.

[23]  T. Umbreit,et al.  Effects of 17α-methyltestosterone on uterine morphology and heat shock protein expression are mediated through estrogen and androgen receptors , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[24]  J. Horiguchi,et al.  Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER α , 2003, International journal of cancer.

[25]  C. Prives,et al.  Why Is p53 Acetylated? , 2001, Cell.

[26]  G. Alton,et al.  Identification of a Structural Determinant , 2002 .

[27]  Norman R. Farnsworth,et al.  Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes , 1997, Science.

[28]  Hung-Yun Lin,et al.  Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. , 2002, The Journal of urology.

[29]  E. Levin,et al.  Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. , 2000, Molecular endocrinology.

[30]  P. Bontempo,et al.  Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells. , 1996, The EMBO journal.

[31]  W. Chung,et al.  Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: structural requirements and mechanism of action. , 2002, Life sciences.

[32]  M L Agarwal,et al.  The p53 Network* , 1998, The Journal of Biological Chemistry.

[33]  Hung-Yun Lin,et al.  Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. , 2002, The Journal of clinical endocrinology and metabolism.

[34]  Weiya Ma,et al.  Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. , 2001, Cancer research.

[35]  J. Pezzuto,et al.  Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. , 2001, Cancer research.

[36]  R. Klinke,et al.  A Chemical Inhibitor of p 53 That Protects Mice from the Side Effects of Cancer Therapy , 1999 .

[37]  Weiya Ma,et al.  Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. , 1999, Carcinogenesis.